dpp-4 inhibitors vs. glp-1 agonist analogues and in type 2 diabetes therapy: from structural biology to clinics Effect of DPP4 inhibition on

The team used a set of biological epigenetic clocks to track cellular aging over the 32-week treatment period

These criteria and collected variables were established to isolate the impact of GLP-1 prescriptions on study outcomes while controlling for potential confounding factors, with a specific focus on the risk of depression, anxiety, and suicide

This remains relatively rare, but coverage is expanding

doi: 10.1161/CIR.0000000000000920 77 PfefferMAClaggettBDiazRDicksteinKGersteinHCKberLVet al

This review seeks to systematically elucidate the relationship between GLP-1RAs and cancer risk, along with the potential underlying mechanisms involved

*Correspondence: Xian-Feng Zhang, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Obesity, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers